Netherlands
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.34 (0.22 - 0.47) | 2016 | Survey/reported | Koopsen J et al, 2019 |
0.2 (0.10 - 0.40) | 2007 | Survey/reported | Hahne SJM et al, 2012 |
0.09 (0.07 - 0.11) | 2015 | Modelled | WHO |
0.3 (0.10 - 0.40) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
0.2 (0.10 - 0.40) | 2007 | Survey/reported | ECDC |
0.4 (0.39 - 0.41) | 2013 | Modelled | Schweitzer et al, 2015 |
0.87 (0.70 - 1.04) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
0.96 (0.78 - 1.14) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.98 (0.79 - 1.16) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.99 (0.82 - 1.17) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.84 - 1.19) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.84 - 1.18) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
1 (0.83 - 1.18) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
1 (0.82 - 1.18) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
1 (0.82 - 1.18) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.99 (0.81 - 1.18) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.99 (0.81 - 1.17) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.98 (0.81 - 1.16) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.98 (0.81 - 1.15) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.97 (0.81 - 1.15) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.97 (0.81 - 1.15) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.98 (0.81 - 1.16) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.99 (0.82 - 1.16) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1 (0.84 - 1.18) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.84 - 1.20) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.02 (0.85 - 1.21) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.02 (0.85 - 1.21) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.02 (0.84 - 1.20) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.84 - 1.19) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.83 - 1.19) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.83 - 1.19) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.84 - 1.20) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.02 (0.84 - 1.20) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.02 (0.84 - 1.21) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.03 (0.85 - 1.23) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.03 (0.85 - 1.24) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.94 (0.77 - 1.13) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.04 (0.03 - 0.05) | 2015 | Modelled | WHO |
0.06 (0.04 - 0.07) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
0.09 (0.06 - 0.13) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.1 (0.07 - 0.13) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.11 (0.07 - 0.15) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.12 (0.08 - 0.16) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.14 (0.09 - 0.19) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.2 (0.13 - 0.27) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.31 (0.21 - 0.42) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.43 (0.29 - 0.59) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.54 (0.35 - 0.73) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.58 (0.38 - 0.79) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.58 (0.39 - 0.79) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.58 (0.39 - 0.78) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.58 (0.39 - 0.77) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.58 (0.39 - 0.76) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.57 (0.39 - 0.77) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.59 (0.40 - 0.78) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.62 (0.42 - 0.83) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.67 (0.44 - 0.88) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.7 (0.46 - 0.94) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.47 - 0.97) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.48 - 0.97) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.47 - 0.96) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.71 (0.46 - 0.95) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.7 (0.45 - 0.95) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.7 (0.45 - 0.96) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.7 (0.45 - 0.94) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.7 (0.45 - 0.94) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.71 (0.46 - 0.95) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.71 (0.47 - 0.97) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.48 - 0.99) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.08 (0.07 - 0.09) | 2020 | Modelled | WHO |
Showing out of
Show more
Pregnant women
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.3 (0.30 - 0.40) | 2016 | Modelled | ECDC |
0.3 (0.30 - 0.40) | 2006 | Survey/reported | Op de Coul EL et al, 2011 |
0.3 (0.30 - 0.40) | 2007 | Survey/reported | Op de Coul EL et al, 2011 |
0.4 (0.40 - 0.40) | 2008 | Survey/reported | Op de Coul EL et al, 2011 |
Showing out of
Show more
Men who have sex with men (MSM)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.48 | 2017 | Survey/reported | ECDC Monitoring Report |
0.83 | 2017 | Survey/reported | ECDC Monitoring Report |
0.83 | 2017 | Survey/reported | ECDC |
0.48 | 2017 | Survey/reported | ECDC |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
47,000 (25,000 - 68,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
148,649 (120,605 - 178,493) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
152,624 (123,734 - 182,491) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
155,581 (126,408 - 184,306) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
157,343 (126,391 - 186,536) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
159,111 (131,213 - 187,383) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
160,262 (133,542 - 188,997) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
159,693 (132,510 - 187,427) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
158,721 (131,106 - 186,565) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
157,499 (129,373 - 185,622) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
156,097 (128,556 - 184,578) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
154,603 (125,453 - 183,503) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
153,078 (125,682 - 181,636) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
151,600 (124,918 - 179,503) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
150,296 (124,446 - 177,663) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
149,265 (123,267 - 176,261) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
148,596 (122,491 - 176,179) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
148,716 (123,103 - 175,520) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
149,633 (124,088 - 176,182) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
150,811 (125,346 - 177,432) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
151,712 (126,365 - 179,249) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
151,840 (125,641 - 180,051) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
150,852 (125,005 - 179,030) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
149,097 (123,373 - 175,760) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
147,141 (121,653 - 173,728) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
145,536 (120,778 - 171,945) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
144,789 (119,933 - 171,741) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
144,616 (119,750 - 171,238) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
144,413 (119,320 - 171,164) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
144,204 (119,347 - 170,707) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
144,018 (119,047 - 171,867) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
143,933 (118,063 - 171,978) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
1.65 (1.27 - 2.11) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
1.29 (0.99 - 1.67) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.32 (1.02 - 1.70) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.35 (1.03 - 1.75) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.42 (1.09 - 1.84) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.46 (1.12 - 1.89) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.4 (1.07 - 1.82) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.49 (1.15 - 1.93) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.48 (1.14 - 1.93) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.52 (1.17 - 1.96) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.57 (1.21 - 2.02) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.6 (1.24 - 2.07) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.63 (1.26 - 2.11) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.68 (1.29 - 2.18) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.74 (1.34 - 2.26) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.67 (1.28 - 2.16) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.63 (1.25 - 2.11) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.61 (1.24 - 2.10) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.61 (1.24 - 2.05) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.6 (1.23 - 2.05) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.61 (1.24 - 2.04) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.62 (1.25 - 2.05) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.61 (1.24 - 2.05) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.61 (1.25 - 2.06) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.56 (1.20 - 1.99) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.58 (1.22 - 2.02) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.58 (1.22 - 2.03) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.62 (1.25 - 2.08) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.64 (1.25 - 2.08) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.64 (1.26 - 2.10) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.65 (1.27 - 2.11) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
484 | 2016 | Modelled | WHO |
193 (148 - 249) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
198 (153 - 255) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
204 (157 - 265) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
218 (167 - 282) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
213 (164 - 277) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
225 (173 - 292) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
229 (176 - 299) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
233 (180 - 301) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
239 (183 - 308) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
247 (191 - 320) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
254 (197 - 329) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
261 (201 - 338) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
271 (207 - 350) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
282 (216 - 365) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
272 (208 - 351) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
266 (204 - 344) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
264 (203 - 343) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
265 (204 - 338) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
262 (201 - 336) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
267 (205 - 337) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
268 (207 - 341) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
268 (206 - 342) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
270 (208 - 345) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
265 (205 - 339) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
262 (202 - 335) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
276 (212 - 353) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
268 (206 - 343) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
279 (213 - 355) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
281 (216 - 359) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
283 (218 - 362) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
283 (218 - 362) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
92 | 2019 | Survey/reported | WHO/UNICEF |
93 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
414 (170 - 659) | 2014 | Survey/reported | van Laar M et al, 2014 |
HBV National Action Plan
HBV elimination goal
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.1 (0 - 0.20) | 2015 | Modelled | Blach et al, 2017 |
0.52 (0.43 - 0.63) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.51 (0.42 - 0.62) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.51 (0.42 - 0.62) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.5 (0.41 - 0.61) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.49 (0.40 - 0.60) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.47 (0.39 - 0.57) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.43 (0.35 - 0.51) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.38 (0.31 - 0.46) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.34 (0.28 - 0.41) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.33 (0.27 - 0.39) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.33 (0.27 - 0.39) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.33 (0.28 - 0.39) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.34 (0.28 - 0.40) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.35 (0.29 - 0.41) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.36 (0.30 - 0.42) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.39 (0.33 - 0.46) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.45 (0.37 - 0.54) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.52 (0.42 - 0.62) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.57 (0.46 - 0.70) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.59 (0.47 - 0.73) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.58 (0.46 - 0.70) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.54 (0.44 - 0.66) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.5 (0.41 - 0.61) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.46 (0.38 - 0.56) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.45 (0.36 - 0.55) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.44 (0.36 - 0.54) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.44 (0.36 - 0.54) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.43 (0.35 - 0.53) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.43 (0.35 - 0.53) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.43 (0.35 - 0.53) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.48 (0.40 - 0.59) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.08 (0.03 - 0.13) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.16 (0.06 - 0.27) | 2019 | Survey/reported | Koopsen J et al, 2019 |
0.1 (0 - 0.20) | 2007 | Survey/reported | Vriend HJ et al, 2013 |
0.2 (0.10 - 0.40) | 2014 | Survey/reported | Gower et al, 2014 |
0.22 | 2019 | Modelled | Jin et al. 2017 |
0.1 (0 - 0.20) | 2007 | Survey/reported | ECDC |
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
8.2 (5.10 - 12.10) | 2019 | Modelled | Jin et al. 2017 |
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
55.3 (49.70 - 60.90) | 2017 | Modelled | Degenhardt L et al, 2017 |
39.3 | 2013 | Survey/reported | EMCDDA |
Showing out of
Show more
Men who have sex with men (MSM)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.3 (0.80 - 1.90) | 2003 | Survey/reported | van de Laar TJ et al , 2007 |
0.7 (0.10 - 1.90) | 2007 | Survey/reported | Van Rooijen MS et al , 2013 |
4.8 | 2017 | Survey/reported | ECDC |
3.7 | 2019 | Modelled | Jin et al. 2017 |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
16,000 (5,000 - 26,000) | 2015 | Modelled | Blach et al, 2017 |
59,544 (48,540 - 73,290) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
60,354 (49,254 - 74,182) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
61,252 (50,054 - 75,253) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
62,177 (50,899 - 76,173) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
63,127 (51,795 - 77,810) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
64,114 (52,386 - 78,743) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
67,053 (54,836 - 81,833) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
72,774 (59,186 - 88,532) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
79,468 (64,510 - 96,772) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
85,268 (68,744 - 104,341) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
88,258 (70,121 - 108,616) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
85,670 (69,307 - 104,064) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
78,015 (64,084 - 94,071) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
68,191 (56,474 - 81,496) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
59,316 (49,630 - 70,390) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
54,616 (45,611 - 64,881) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
53,163 (44,366 - 63,083) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
51,943 (43,214 - 61,570) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
51,041 (42,427 - 60,699) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
50,585 (41,733 - 60,410) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
50,706 (41,670 - 60,833) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
53,543 (43,766 - 64,133) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
59,887 (49,091 - 71,650) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
67,659 (55,665 - 80,855) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
74,738 (61,395 - 89,890) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
78,868 (64,381 - 95,391) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
80,464 (66,195 - 96,891) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
81,675 (67,073 - 99,250) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
82,731 (68,211 - 100,472) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
83,699 (68,826 - 102,169) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
82,650 (67,911 - 101,039) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
3,000 (940 - 4,600) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
3.62 (2.86 - 4.43) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
2.23 (1.77 - 2.78) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.33 (1.86 - 2.91) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.27 (1.81 - 2.83) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.46 (1.95 - 3.05) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.42 (1.92 - 3) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.53 (2.01 - 3.14) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.56 (2.05 - 3.17) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.61 (2.09 - 3.22) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.66 (2.12 - 3.29) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.73 (2.17 - 3.39) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.78 (2.21 - 3.50) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.95 (2.33 - 3.65) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.85 (2.27 - 3.56) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.04 (2.41 - 3.77) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.95 (2.33 - 3.66) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.91 (2.30 - 3.59) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.9 (2.29 - 3.60) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.96 (2.37 - 3.63) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.91 (2.33 - 3.58) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.99 (2.38 - 3.67) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.03 (2.40 - 3.72) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.09 (2.46 - 3.81) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.2 (2.57 - 3.95) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.24 (2.58 - 3.99) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.4 (2.69 - 4.19) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.29 (2.59 - 4.05) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.5 (2.80 - 4.29) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.52 (2.76 - 4.31) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.56 (2.81 - 4.36) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.62 (2.86 - 4.43) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
634 | 2016 | Modelled | WHO |
621 (491 - 760) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
621 (491 - 760) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
609 (480 - 746) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
599 (471 - 734) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
595 (476 - 728) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
575 (455 - 708) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
554 (437 - 683) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
543 (433 - 670) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
535 (430 - 661) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
516 (410 - 635) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
503 (398 - 618) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
495 (394 - 607) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
487 (391 - 598) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
478 (382 - 587) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
476 (377 - 587) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
473 (373 - 587) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
479 (378 - 594) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
492 (389 - 609) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
474 (375 - 586) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
456 (363 - 569) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
442 (351 - 556) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
431 (343 - 536) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
417 (333 - 516) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
407 (326 - 502) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
398 (317 - 492) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
390 (311 - 484) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
376 (299 - 467) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
368 (292 - 457) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
352 (281 - 441) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
342 (272 - 426) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
332 (264 - 415) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
414 (170 - 659) | 2014 | Survey/reported | van Laar M et al, 2014 |
HBV National Action Plan
HBV elimination goal
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Modelled
HBV
283
2019
(218 - 362)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
621
2019
(491 - 760)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
0.08
(%)
2020, latest modelled
(0.07 - 0.09(%))
WHO
Prevalence PWID
HCV
39.30
(%)
2013, survey/surveillance
EMCDDA
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines